Virtus ETF Advisers’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,280
| Closed | -$352K | – | 600 |
|
|
2024
Q4 | $352K | Sell |
6,280
-1,143
| -15% | -$64K | 0.14% | 198 |
|
|
2024
Q3 | $389K | Hold |
7,423
| – | – | 0.18% | 206 |
|
|
2024
Q2 | $305K | Sell |
7,423
-1,451
| -16% | -$59.6K | 0.15% | 227 |
|
|
2024
Q1 | $385K | Buy |
8,874
+1,277
| +17% | +$55.3K | 0.2% | 200 |
|
|
2023
Q4 | $349K | Sell |
7,597
-9,596
| -56% | -$441K | 0.22% | 187 |
|
|
2023
Q3 | $394K | Sell |
17,193
-2,221
| -11% | -$50.9K | 0.24% | 180 |
|
|
2023
Q2 | $320K | Buy |
19,414
+9,010
| +87% | +$149K | 0.19% | 186 |
|
|
2023
Q1 | $186K | Buy |
10,404
+183
| +2% | +$3.27K | 0.1% | 312 |
|
|
2022
Q4 | $298K | Buy |
+10,221
| New | +$298K | 0.16% | 269 |
|
|
2022
Q2 | – | Sell |
-16,317
| Closed | -$188K | – | 469 |
|
|
2022
Q1 | $188K | Sell |
16,317
-973
| -6% | -$11.2K | 0.08% | 201 |
|
|
2021
Q4 | $173K | Buy |
17,290
+7,061
| +69% | +$70.7K | 0.07% | 271 |
|
|
2021
Q3 | $134K | Sell |
10,229
-536
| -5% | -$7.02K | 0.06% | 360 |
|
|
2021
Q2 | $211K | Buy |
10,765
+826
| +8% | +$16.2K | 0.09% | 308 |
|
|
2021
Q1 | $211K | Buy |
9,939
+167
| +2% | +$3.55K | 0.09% | 320 |
|
|
2020
Q4 | $291K | Sell |
9,772
-5,612
| -36% | -$167K | 0.12% | 227 |
|
|
2020
Q3 | $333K | Sell |
15,384
-2,100
| -12% | -$45.5K | 0.17% | 201 |
|
|
2020
Q2 | $390K | Buy |
17,484
+2,260
| +15% | +$50.4K | 0.18% | 209 |
|
|
2020
Q1 | $232K | Sell |
15,224
-2,226
| -13% | -$33.9K | 0.1% | 264 |
|
|
2019
Q4 | $401K | Buy |
17,450
+6,142
| +54% | +$141K | 0.07% | 252 |
|
|
2019
Q3 | $244K | Sell |
11,308
-630
| -5% | -$13.6K | 0.05% | 218 |
|
|
2019
Q2 | $263K | Buy |
11,938
+2,470
| +26% | +$54.4K | 0.06% | 264 |
|
|
2019
Q1 | $260K | Sell |
9,468
-1,044
| -10% | -$28.7K | 0.55% | 75 |
|
|
2018
Q4 | $283K | Sell |
10,512
-3,532
| -25% | -$95.1K | 0.05% | 132 |
|
|
2018
Q3 | $410K | Sell |
14,044
-10,330
| -42% | -$302K | 0.04% | 156 |
|
|
2018
Q2 | $762K | Buy |
+24,374
| New | +$762K | 0.67% | 62 |
|